Trinity Capital, a US financier to high-growth companies, has announced a $35 million equipment financing facility for ApiJect Systems, a medical technology company specialising in prefilled, single-dose injection devices.
ApiJect, based in Stamford, Connecticut, US, partners with pharmaceutical companies to design scalable and cost-efficient drug delivery systems. The company’s goal is to make liquid medicines and vaccines more accessible and safer for patients globally.
Go deeper with GlobalData
The financing from Trinity Capital will allow ApiJect to optimise the value of its assets, expanding operations and supporting its growth ambitions.
“We are pleased to back ApiJect in their mission to improve access to injectable medicines and vaccines,” said Melana Ferguson, Director of Equipment Finance at Trinity. “We are eager to work alongside their leadership team to help drive their growth.”
Jay Walker, Co-Founder, Executive Chairman, and CEO of ApiJect, commented on the new financing, stating, “With Trinity’s partnership, we are well positioned to expand our manufacturing capacity in the U.S., pursue regulatory approval for our first device, and collaborate with pharmaceutical companies interested in our injection technology.”
Trinity Capital specialises in term loans, equipment financings, and equity-related investments, with a focus on generating income and capital growth.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalData
